Brand Name | Status | Last Update |
---|---|---|
amrix | New Drug Application | 2024-04-30 |
cyclo/gaba 10/300 pack | ANDA | 2016-06-22 |
cyclo/mag | unapproved drug other | 2010-03-05 |
cyclo/mag 10mg/200mg | unapproved drug other | 2010-02-17 |
cyclobenzaprine | ANDA | 2024-08-06 |
cyclobenzaprine cyclobenzaprine hydrochloride | ANDA | 2023-04-17 |
cyclobenzaprine hci | ANDA | 2019-04-02 |
cyclobenzaprine hci cyclobenzaprine hcl | ANDA | 2023-06-06 |
cyclobenzaprine hci cyclobenzaprine hcl cyclobenzprine hcl | ANDA | 2019-04-04 |
cyclobenzaprine hcl | ANDA | 2024-12-31 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
myositis | EFO_0000783 | D009220 | G72.49 |
pain | EFO_0003843 | D010146 | R52 |
muscle spasticity | — | D009128 | — |
muscle cramp | — | D009120 | — |
spasm | — | D013035 | M62.83 |
tetanus | EFO_0005593 | D013742 | A35 |
muscle rigidity | — | D009127 | — |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Migraine disorders | D008881 | EFO_0003821 | G43 | — | — | 1 | — | — | 1 |
Drug common name | Cyclobenzaprine |
INN | cyclobenzaprine |
Description | Cyclobenzaprine is 5-Methylidene-5H-dibenzo[a,d]cycloheptene in which one of the hydrogens of the methylidene group is substituted by a 2-(dimethylamino)ethyl group. A centrally acting skeletal muscle relaxant, it is used as its hydrochloride salt in the symptomatic treatment of painful muscle spasm. It has a role as a muscle relaxant, a tranquilizing drug and an antidepressant. It derives from a hydride of a dibenzo[a,d][7]annulene. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CN(C)CCC=C1c2ccccc2C=Cc2ccccc21 |
PDB | — |
CAS-ID | 303-53-7 |
RxCUI | — |
ChEMBL ID | CHEMBL669 |
ChEBI ID | 3996 |
PubChem CID | 2895 |
DrugBank | DB00924 |
UNII ID | 69O5WQQ5TI (ChemIDplus, GSRS) |